Does zafirlukast reduce future risk of asthma exacerbations in adults? Systematic review and meta-analysis

Conclusions Our study suggests that zafirlukast, as the first-line therapy, significantly reduces mild to moderate but not severe asthma exacerbations. In the add-on regimen, zafirlukast could not reduce asthma exacerbations, which would perhaps result from small sample size and needs to be further studied.
Source: Multidisciplinary Respiratory Medicine - Category: Respiratory Medicine Source Type: research